Recombinant Measles Virus for Waterborne Pathogen Detection and Treatment

Publication ID: 24-11857616_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Recombinant Measles Virus for Waterborne Pathogen Detection and Treatment,” Published Technical Disclosure No. 24-11857616_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857616_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,616.

Summary of the Inventive Concept

A novel system utilizing a recombinant measles virus expressing Zika virus prM and E proteins for detecting and monitoring waterborne pathogens, treating wastewater, and preventing Zika virus transmission in mosquitoes and agricultural settings.

Background and Problem Solved

The original patent disclosed a recombinant measles virus expressing Zika virus prM and E proteins for vaccine development. However, this technology has limitations in addressing the growing concern of waterborne pathogens and Zika virus transmission in non-human settings. The new inventive concept addresses these limitations by applying the core technology to an entirely different industry, field, or problem, providing a novel solution for waterborne pathogen detection, wastewater treatment, and Zika virus prevention.

Detailed Description of the Inventive Concept

The inventive concept comprises a recombinant measles virus expressing Zika virus prM and E proteins, engineered to target and bind to specific waterborne pathogens, facilitating their detection and removal from wastewater. The system can be used for monitoring and tracking the spread of Zika virus in agricultural settings, and for treating and preventing Zika virus transmission in mosquitoes. The recombinant measles virus can be immobilized on a surface to create a biosensor for detecting Zika virus in food products, providing a rapid and accurate detection method.

Novelty and Inventive Step

The new claims introduce a novel application of the recombinant measles virus technology, expanding its use beyond vaccine development to address waterborne pathogen detection, wastewater treatment, and Zika virus prevention. The inventive step lies in the engineering of the prM and E proteins to target specific waterborne pathogens, and the development of a system for detecting and monitoring these pathogens in various settings.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept include the use of different viral vectors, such as adenovirus or lentivirus, to express the Zika virus prM and E proteins. Variations of the system could include the use of different detection methods, such as PCR or ELISA, and the development of portable or handheld biosensors for on-site detection.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the water treatment, agricultural, and food safety industries. The system could be marketed as a solution for detecting and monitoring waterborne pathogens, treating wastewater, and preventing Zika virus transmission in mosquitoes and agricultural settings. The biosensor component could be marketed as a rapid and accurate detection method for Zika virus in food products.

CPC Classifications

SectionClassGroup
A A61 A61K39/12
C C07 C07K14/005
C C12 C12N7/00
A A61 A61K2039/5254
A A61 A61K2039/53
C C12 C12N2760/18421
C C12 C12N2760/18423
C C12 C12N2770/24122
C C12 C12N2770/24123
C C12 C12N2770/24134

Original Patent Information

Patent NumberUS 11,857,616
TitleRecombinant measles virus expressing zika virus prM and E proteins
Assignee(s)CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), Institut Pasteur